{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:11:00Z","timestamp":1792393860898,"version":"4.4.0"},"reference-count":16,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Dermatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dermal fillers have gained increasing popularity for their ability to enhance facial symmetry, restore volume, and improve skin texture. However, their use in patients with cancer undergoing active chemotherapy and radiation therapy poses unique challenges, as these treatments can alter both the safety profile and efficacy of filler procedures. Chemotherapy can interfere with normal wound healing and immune responses, warranting a more cautious and individualized approach when considering dermal fillers in this population. Although rare, dermal fillers have been associated with adverse outcomes in a limited number of diseases, including cellulitis, autoimmune\/inflammatory syndrome induced by adjuvants, and a possible predisposition to malignancy. Other effects include localized inflammatory, systemic hypersensitivity, and delayed granulomatous formation, and these could be more severe in patients undergoing antineoplastic therapy. Furthermore, chemotherapy is often paired with adjuvant radiation therapy in cancer treatment, making it important to note the potential changes radiation can have on the skin. More research is needed to examine the direct interactions of chemotherapy and radiation on various filler materials injected within the skin, and how these can alter one\u2019s risk of adverse effects. The lack of research on this topic further emphasizes that clinicians should thoroughly educate patients receiving chemotherapy and adjuvant radiation treatment about the heightened potential risks associated with dermal filler injections and treatment regimens should be planned accordingly to minimize any adverse events.<\/jats:p>","DOI":"10.2196\/76898","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:20:57Z","timestamp":1757463657000},"page":"e76898-e76898","source":"Crossref","is-referenced-by-count":2,"title":["Dermal Filler Use in Patients Undergoing Chemotherapy and Radiation Therapy"],"prefix":"10.2196","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1518-3548","authenticated-orcid":false,"given":"Mia","family":"Panlilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2514-7621","authenticated-orcid":false,"given":"Elizabeth","family":"Tchernogorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1741-4395","authenticated-orcid":false,"given":"Binh Minh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1172-8312","authenticated-orcid":false,"given":"Sana","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8383-0601","authenticated-orcid":false,"given":"Leslie","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"34","key":"R1","doi-asserted-by":"publisher","first-page":"23841","DOI":"10.1039\/d3ra04321e","article-title":"Injectable fillers: current status, physicochemical properties, function mechanism, and perspectives","volume":"13","author":"Guo","journal-title":"RSC Adv"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Tejero P Pinto H , editors. Aesthetic Treatments for the Oncology Patient. 1st ed. CRC Press; 2020. URL: https:\/\/doi.org\/10.1201\/9780203728888 [Accessed 25-08-2025] [doi: 10.1201\/9780203728888]","DOI":"10.1201\/9780203728888-1"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000005579","article-title":"The research trend of soft tissue filler injection from 2000 to 2022: a bibliometric and visualized analysis","volume":"12","author":"Liao","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"16_suppl","key":"R4","doi-asserted-by":"publisher","first-page":"e23245","DOI":"10.1200\/JCO.2024.42.16_suppl.e23245","article-title":"Aesthetics treatment with injectable fillers in patients with cancer: safety and quality of life during active antineoplastic therapy","volume":"42","author":"Shachar","journal-title":"JCO"},{"issue":"8","key":"R5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228882","article-title":"Cetuximab associated dermal filler reaction","volume":"12","author":"Pathmanathan","journal-title":"BMJ Case Rep"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S342734","article-title":"Aesthetic treatments in cancer patients","volume":"14","author":"Proietti","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S419716","article-title":"Hyaluronic acid fillers and ASIA syndrome: case studies","volume":"16","author":"Owczarczyk-Saczonek","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"779-814","key":"R8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2147\/CCID.S315711","article-title":"The 10-point plan 2021: updated concepts for improved procedural safety during facial filler treatments","volume":"14","author":"Heydenrych","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2147\/cia.s382","article-title":"Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers","volume":"2","author":"Edwards","journal-title":"Clin Interv Aging"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2005.05.006","article-title":"The emerging role of CD44 in regulating skeletal micrometastasis","volume":"237","author":"Hill","journal-title":"Cancer Lett"},{"issue":"5","key":"R11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000487601","article-title":"Dermal filler injections mimic tumor activity during immune checkpoint inhibition","volume":"95","author":"Syunyaeva","journal-title":"Respiration"},{"issue":"6","key":"R12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/bjd.14674","article-title":"Foreign body reaction triggered by cytotoxic T lymphocyte-associated protein 4 blockade 25 years after dermal filler injection","volume":"175","author":"Bisschop","journal-title":"Br J Dermatol"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14764172.2018.1525745","article-title":"Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate","volume":"21","author":"Sung","journal-title":"J Cosmet Laser Ther"},{"issue":"12","key":"R14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/1346-8138.12669","article-title":"Changes in biophysical properties of the skin following radiotherapy for breast cancer","volume":"41","author":"Hu","journal-title":"J Dermatol"},{"issue":"30","key":"R15","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","journal-title":"J Clin Oncol"},{"issue":"2","key":"R16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF01570345","article-title":"The history of injectable biomaterials and the biology of collagen","volume":"9","author":"Matton","journal-title":"Aesthetic Plast Surg"}],"container-title":["JMIR Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/derma.jmir.org\/2025\/1\/e76898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:08:49Z","timestamp":1782842929000},"score":1,"resource":{"primary":{"URL":"https:\/\/derma.jmir.org\/2025\/1\/e76898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.2196\/76898","relation":{},"ISSN":["2562-0959"],"issn-type":[{"value":"2562-0959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"article-number":"v8i34e76898"}}